Literature DB >> 970989

Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients.

A L Schroeter, D L Conn, R E Jordon.   

Abstract

Rheumatoid arthritis (RA) was differentiated from systemic lupus erythematosus (SLE) by direct immunofluorescent techniques on skin specimens, using monospecific antisera for IgG, IgM, C3, C1q, properdin, and fibrin. Of 30 patients with RA studied, 20 had dermal vessel deposits of immunoglobulins and complement components in unaffected skin without the characteristic dermal-epidermal junctional fluorescence of SLE. Of 24 SLE patients studied, 24 had granular deposits of immunoglobulins and complement components in unaffected skin at the dermal-epidermal junction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 970989      PMCID: PMC1007389          DOI: 10.1136/ard.35.4.321

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Peripheral vascular obstruction in rheumatoid arthritis and its relationship to other vascular lesions.

Authors:  E G BYWATERS
Journal:  Ann Rheum Dis       Date:  1957-03       Impact factor: 19.103

3.  The relationship of therapy with cortisone to the incidence of vascular lesions in rheumatoid arthritis.

Authors:  J W KEMPER; A H BAGGENSTOSS; C H SLOCUMB
Journal:  Ann Intern Med       Date:  1957-05       Impact factor: 25.391

4.  Properties of highly purified human properdin.

Authors:  J Ensky; C F Hinz; E W Todd; R J Wedgwood; J T Boyer; I H Lepow
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

5.  Glomerular and dermal depostion of properdin in systemic lupus erythematosus.

Authors:  N Rothfield; H A Ross; J O Minta; I H Lepow
Journal:  N Engl J Med       Date:  1972-10-05       Impact factor: 91.245

6.  Localization of various plasma proteins in the skin in rheumatoid arthritis. An immunofluorescent microscopic study of skin biopsies.

Authors:  O Larsson; F Lithner
Journal:  Acta Med Scand       Date:  1972 Jul-Aug

7.  Dermal-epidermal deposition of complement components and properdin in systemic lupus erythematosus.

Authors:  R E Jordon; A L Schroeter; R K Winkelmann
Journal:  Br J Dermatol       Date:  1975-03       Impact factor: 9.302

8.  Role of IgG and IgM antinuclear antibodies in formation of lupus erythematosus cells and extracellular material.

Authors:  C Blondin; F C McDuffie
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

9.  Studies into the occurrence of soluble antigen-antibody complexes in disease. V. Second assessment of correlation between the rheumatoid biologically active factor (RBAF) and the clinical features of rheumatoid arthritis.

Authors:  M B Urowitz; D A Gordon; I Broder
Journal:  Arthritis Rheum       Date:  1973 Mar-Apr

10.  IMMUNOLOGICAL STUDIES OF THE 11S PROTEIN COMPONENT OF THE HUMAN COMPLEMENT SYSTEM.

Authors:  J H MORSE; C L CHRISTIAN
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

View more
  9 in total

1.  Immunoglobulin and complement in normal skin.

Authors:  W K Blenkinsopp; R J Clayton; G P Haffenden
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

2.  Immunofluorescence of the skin in gold rashes - with particular reference to IgE.

Authors:  J M Iveson; D G Scott; W D Perera; W J Cunliffe; V Wright
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

Review 3.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

4.  Immune deposits at the dermoepidermal junction in patients with rheumatoid arthritis.

Authors:  P A Brougham; P E McGill; J Tulloch
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

Review 5.  Diagnosis and management of leukocytoclastic vasculitis.

Authors:  Paolo Fraticelli; Devis Benfaremo; Armando Gabrielli
Journal:  Intern Emerg Med       Date:  2021-03-13       Impact factor: 3.397

6.  High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.

Authors:  Deena A Abdulahad; Johanna Westra; Johannes Bijzet; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Journal:  Arthritis Res Ther       Date:  2011-05-06       Impact factor: 5.156

7.  Dyshidrotic eczema: relevance to the immune response in situ.

Authors:  Ana Maria Abreu-Velez; Frank J Pinto; Michael S Howard
Journal:  N Am J Med Sci       Date:  2009-08

Review 8.  Rheumatoid arthritis and systemic lupus erythematosus: Pathophysiological mechanisms related to innate immune system.

Authors:  Maria Angélica Pabón-Porras; Sebastian Molina-Ríos; Jorge Bruce Flórez-Suárez; Paola Ximena Coral-Alvarado; Paul Méndez-Patarroyo; Gerardo Quintana-López
Journal:  SAGE Open Med       Date:  2019-09-13

Review 9.  Lupus pathobiology based on genomics.

Authors:  Mohammad Saeed
Journal:  Immunogenetics       Date:  2016-12-08       Impact factor: 2.846

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.